Free CME from PeerView


Pathology CME

Credits: 1.50 CME / MOC / NCPD
Medical Learning Institute, Inc.
The Expanding Advanced Ovarian Cancer Treatment Palette: Candid Conversations on Bringing PARP Inhibitors Into Clinical Practice
July 6, 2021
Credits: 1.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Innovative Immunotherapy in Advanced Basal Cell Carcinoma: Evolving Science, Key Clinical Evidence, and Implications for Multidisciplinary Management
June 25, 2021
Credits: 1.50 CME / MOC / CC
Medical Learning Institute, Inc.
Revisiting PD-L1 as an Immunotherapy Biomarker Across the Cancer Spectrum: Current and Emerging Standards of Testing, Scoring, and Assay Interpretation
May 11, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Precision Decisions in Genomic Testing and Targeted Treatment of NSCLC
April 13, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
HER2 and HER3 Alterations as Therapeutic Targets of Increasing Significance in Solid Tumors: Implications for Pathology and Oncology Practice
April 6, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
New Horizons in EGFR-Mutated NSCLC: Broadening the Impact of Precision Testing in the Context of an Expanding Treatment Landscape
January 26, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
The Pathology–Oncology Partnership in AML: Identifying and Treating the Diversity of Disease Subtypes
October 15, 2020